目的 观察尪痹片口服治疗联合关节松动术治疗肩周炎的临床应用效果,为肩周炎的治疗提供参考.方法 选取本院2015年1月～2016年6月收治的肩周炎患者136例为研究对象,按照住院先后顺序随机分为观察组和对照组,每组68例,观察组采用尪痹片口服联合关节松动术治疗,对照组采用单独的关节松动术进行治疗.治疗后对2组患者的临床疗效、并发症或不良反应进行统计对比,采用视觉模拟评分法(visual analogue scale, VAS)对患者治疗前后的肩关节疼痛程度进行评分比较,日本矫形外科协会(Japanese Orthopaedic Association,JOA)的肩部疾患评分标准对患者的肩关节运动功能进行评分对比,对患者进行为期半年的随访并采用Barthel指数评分法对患者日常生活动能力进行评分对比.结果 (1)观察组临床治疗总有效率为94.12%(64/68),对照组患者为82.35%(56/68),观察组疗效优于对照组(P＜0.05).(2)观察组不良反应发生率为11.76%(8/68),对照组患者为7.35%(5/68),2组患者治疗安全性良好.(3)观察组治疗后VAS评分为(3.09±0.98)分,对照组为(4.53±1.02)分,观察组疼痛程度显著低于对照组(P＜0.05).(4)治疗后观察组JOA评分为(16.54±2.36)分,对照组为(12.97±2.71)分,观察组肩关节运动功能显著高于对照组(P＜0.05).(5)观察组治疗及随访时的Barthel指数评分为(73.11±6.21)、(83.89±7.95)分,对照组则为(68.41±5.65)、(73.88±6.80)分,观察组日常生活活动能力高于对照组(P＜0.05).结论 尪痹片口服治疗联合关节松动术治疗肩周炎疗效显著,安全性高,能够缓解患者的疼痛、提高肩关节活动功能和日常生活活动能力,该治疗方法疗效全面,有较高的临床应用价值.%Objective To observe the clinical effect of Wangbi tablet oral therapy combined with joint mobilization in the treatment of periarthritis of shoulder, to provide reference for the treatment of periarthritis of shoulder.Methods A total of 136 patients with scapulohumeral periarthritis in our hospital from January 2015 to June 2016 were selected as the research object, according to the order of hospitalized patients were randomly divided into observation group and control group,with 68 cases in each group, the observation group was treated with Wangbi tablet combined with joint mobilization,the control group was treated with single joint mobilization.After treatment, the clinical curative effect,complications or adverse reactions were comparedbetween the two groups, visual analogue scale(VAS)was used to compare the degree of pain of shoulder joint of patients before and after treatment, the shoulder joint function score were compared by the Japanese Orthopedic Association(JOA)'s shoulder disease score, the patients were followed up for a half a year and the Barthel index score was used to compare the daily life ability score of dynamic contrast.Results (1)The total effective rate of the observation group was(64/68), the control group was 82.35%(56/68), the observation group was significantly better than the control group(P<0.05).(2)The incidence of adverse reactions in the observation group was(8/68), the control group was 7.35%(5/68), and the safety of the two groups was good.(3)the VAS score of the observation group was(3.09±0.98), the control group was(4.53±1.02), and the pain of the observation group was significantly lower than that of the control group(P<0.05).(4)After treatment, the JOA score of the observation group was(16.54±2.36), and the control group was(12.97±2.71).The observation group was significantly higher than the control group(P<0.05).(5)The observation group treatment and follow-up of the Barthel index score was(73.11±6.21),(83.89±7.95)points, the control group was(68.41±5.65),(73.88±6.80), the activities of daily living of the observation group were higher than that of the control group(P<0.05).Conclusion There is a significant effect of Wangbi tablet therapy combined with joint mobilization for the treatment of patients with periarthritis of shoulder, the safety of the treatment is high, can reduce the pain of patients, improve the activity of shoulder joint function and activity of daily living, the comprehensive curative effect, with a high clinical value to promote.
展开▼
